A detailed history of Covington Capital Management transactions in Cybin Inc. stock. As of the latest transaction made, Covington Capital Management holds 10,000 shares of CYBN stock, worth $99,100. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Holding current value
$99,100
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.48 - $1.11 $4,800 - $11,100
10,000 New
10,000 $5,000

Others Institutions Holding CYBN

About CYBIN INC.


  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $1.65B
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track Covington Capital Management Portfolio

Follow Covington Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covington Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Covington Capital Management with notifications on news.